Home > Annual Financials > LACTOSE (INDIA)

LACTOSE (INDIA) Financial Statement Analysis
[BOM: 524202]

The Revenues of LACTOSE (INDIA) have increased by 73.10% YoY .
The Earnings Per Share (EPS) of LACTOSE (INDIA) has increased by 461.46 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

LACTOSE (INDIA) Last 5 Annual Financial Results
[BOM: 524202]

StandaloneMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹114 Cr₹66 Cr₹46 Cr₹35 Cr₹40 Cr
Expenses ₹95 Cr₹54 Cr₹34 Cr₹29 Cr₹31 Cr
Operating Profit (Excl OI) ₹19 Cr₹11 Cr₹12 Cr₹6.22 Cr₹9.27 Cr
Other Income ₹1.15 Cr₹0.72 Cr₹0.58 Cr₹0.31 Cr₹0.30 Cr
Interest ₹5.24 Cr₹5.95 Cr₹5.12 Cr₹5.45 Cr₹5.56 Cr
Depreciation ₹5.22 Cr₹4.69 Cr₹4.56 Cr₹4.36 Cr₹3.91 Cr
Profit Before Tax ₹9.66 Cr₹1.46 Cr₹3.17 Cr₹-3.27 Cr₹0.10 Cr
Profit After Tax ₹6.79 Cr₹1.21 Cr₹2.45 Cr₹-2.48 Cr₹0.07 Cr
Earnings Per Share (Rs)₹5.39₹0.96₹1.95₹-2.17₹0.07
PAT Margin (%)5.961.845.34-7.090.18
ROE(%)15.493.036.65-7.210.21
ROCE(%)18.169.2710.212.817.84
Total Debt/Equity(x)0.810.951.061.341.14

Key Financials

Market Cap : ₹ 287.0 Cr
Revenue (TTM) : ₹ 121.9 Cr
Net Profit(TTM) : ₹ 9.3 Cr
EPS (TTM) : ₹ 7.4
P/E (TTM) : 30.8

Industry Peers & Returns1W1M1Y
LACTOSE (INDIA) -0.8% 32.9% 131.3%
SUN PHARMACEUTICAL INDUSTRIES -0.1% 1.7% 45.7%
CIPLA 1.7% 0.5% 23.7%
DR REDDYS LABORATORIES 5.7% 12.4% 18.5%
ZYDUS LIFESCIENCES -1.4% 3.1% 44.8%
DIVIS LABORATORIES -0.1% -2.2% 56.9%
MANKIND PHARMA 4.2% 9.8% 49.8%
TORRENT PHARMACEUTICALS 2.2% 10.6% 61.7%
LUPIN 4.1% 5.1% 71.7%


LACTOSE (INDIA) Revenues
[BOM: 524202]

Y-o-Y

73.10 %

5 Yr CAGR

29.86 %

Years Revenues % Change
Mar2024 ₹114 Cr
73.10
Mar2023 ₹66 Cr
43.22
Mar2022 ₹46 Cr
31.39
Mar2021 ₹35 Cr
-12.70
Mar2020 ₹40 Cr -


LACTOSE (INDIA) Operating Profit
[BOM: 524202]

Y-o-Y

66.69 %

5 Yr CAGR

19.61 %

Years Operating Profit % Change
Mar2024 ₹19 Cr
66.69
Mar2023 ₹11 Cr
-7.20
Mar2022 ₹12 Cr
97.04
Mar2021 ₹6.22 Cr
-32.85
Mar2020 ₹9.27 Cr -

Operating Margins
Y-o-Y

-3.70 %

5 Yr CAGR

-7.90 %

Years Operating Margin% % Change
Mar2024 16.65%
-3.70
Mar2023 17.29%
-35.22
Mar2022 26.69%
49.94
Mar2021 17.8%
-23.08
Mar2020 23.14% -

LACTOSE (INDIA) Profit After Tax
[BOM: 524202]

Y-o-Y

461.54 %

5 Yr CAGR

211.61 %

Years Profit After Tax % Change
Mar2024 ₹6.79 Cr
461.54
Mar2023 ₹1.21 Cr
-50.67
Mar2022 ₹2.45 Cr
Positive
Mar2021 ₹-2.48 Cr
Negative
Mar2020 ₹0.07 Cr -

PAT Margins
Y-o-Y

223.91 %

5 Yr CAGR

139.88 %

Years PAT Margin(%) % Change
Mar2024 5.96 %
223.91
Mar2023 1.84 %
-65.54
Mar2022 5.34 %
Positive
Mar2021 -7.09 %
Negative
Mar2020 0.18 % -

LACTOSE (INDIA) Earnings Per Share (EPS)
[BOM: 524202]

Y-o-Y

461.46 %

5 Yr CAGR

196.23 %

Years EPS % Change
Mar2024 ₹5.39
461.46
Mar2023 ₹0.96
-50.77
Mar2022 ₹1.95
Positive
Mar2021 ₹-2.17
Negative
Mar2020 ₹0.07 -

LACTOSE (INDIA) Return on Capital Employed (ROCE)
[BOM: 524202]

Y-o-Y

95.90 %

5 Yr CAGR

23.37 %

Years ROCE % Change
Mar2024 18.16%
95.90
Mar2023 9.27%
-9.21
Mar2022 10.21%
263.35
Mar2021 2.81%
-64.16
Mar2020 7.84% -

LACTOSE (INDIA) Share Price vs Sensex

Current Share Price : ₹227.8
Current MarketCap: ₹ 287.0 Cr
Updated EOD on :Dec 20,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-0.8%

32.9%

131.3%

SENSEX

-5%

0.6%

9.2%

LACTOSE (INDIA) related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about LACTOSE (INDIA) Financials


How the annual revenues of LACTOSE (INDIA) have changed ?

The Revenues of LACTOSE (INDIA) have increased by 73.10% YoY .

How the Earnings per Share (EPS) of LACTOSE (INDIA) have changed?

The Earnings Per Share (EPS) of LACTOSE (INDIA) has increased by 461.46 % YoY .